In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...
16don MSN
Ozempic, Wegovy are getting generics as low as $15 around the world — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...
Do you take any medications? Nearly half of all Americans take prescription drugs (Demography, Oct. 1, 2023). Make that 85 ...
The simultaneous patent expiry of Ozempic’s active ingredient in China and India on Friday is a watershed moment. Until now, ...
11don MSN
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but ...
This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...
Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results